Biopolymer Drug Delivery Systems for Oromucosal Application: Recent Trends in Pharmaceutical R&D
International Journal of Molecular Sciences · 14.05.2024 · 25 (10) · 5359
DOI: 10.3390/ijms25105359 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.05.2024. Verfasst von Natallia V Dubashynskaya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Macromolecular Compounds of the Russian Academy of Sciences, Bolshoi VO 31, 199004 St. Petersburg, Russia. Hauptthemen laut MEDLINE: Drug Delivery Systems, Mouth Mucosa. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 240 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: St. Petersburg Science Foundation.
Abstract (Originalsprache)
Oromucosal drug delivery, both local and transmucosal (buccal), is an effective alternative to traditional oral and parenteral dosage forms because it increases drug bioavailability and reduces systemic drug toxicity. The oral mucosa has a good blood supply, which ensures that drug molecules enter the systemic circulation directly, avoiding drug metabolism during the first passage through the liver. At the same time, the mucosa has a number of barriers, including mucus, epithelium, enzymes, and immunocompetent cells, that are designed to prevent the entry of foreign substances into the body, which also complicates the absorption of drugs. The development of oromucosal drug delivery systems based on mucoadhesive biopolymers and their derivatives (especially thiolated and catecholated derivatives) is a promising strategy for the pharmaceutical development of safe and effective dosage forms. Solid, semi-solid and liquid pharmaceutical formulations based on biopolymers have several advantageous properties, such as prolonged residence time on the mucosa due to high mucoadhesion, unidirectional and modified drug release capabilities, and enhanced drug permeability. Biopolymers are non-toxic, biocompatible, biodegradable and may possess intrinsic bioactivity. A rational approach to the design of oromucosal delivery systems requires an understanding of both the anatomy/physiology of the oral mucosa and the physicochemical and biopharmaceutical properties of the drug molecule/biopolymer, as presented in this review. This review summarizes the advances in the pharmaceutical development of mucoadhesive oromucosal dosage forms (e.g., patches, buccal tablets, and hydrogel systems), including nanotechnology-based biopolymer nanoparticle delivery systems (e.g., solid lipid particles, liposomes, biopolymer polyelectrolyte particles, hybrid nanoparticles, etc.).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Macromolecular Compounds of the Russian Academy of Sciences, Bolshoi VO 31, 199004 St. Petersburg, Russia.
ORCID-Profile: Natallia V Dubashynskaya, Yury A Skorik
Förderung
- St. Petersburg Science Foundation
Zitieren
APA
Dubashynskaya, N. V., Petrova, V. A., & Skorik, Y. A. (2024). Biopolymer Drug Delivery Systems for Oromucosal Application: Recent Trends in Pharmaceutical R&D. International Journal of Molecular Sciences, 25(10), 5359. https://doi.org/10.3390/ijms25105359
Vancouver
Dubashynskaya NV, Petrova VA, Skorik YA. Biopolymer Drug Delivery Systems for Oromucosal Application: Recent Trends in Pharmaceutical R&D. International Journal of Molecular Sciences. 2024;25(10):5359. doi:10.3390/ijms25105359
BibTeX
@article{Dubashynskaya2024,
author = {Dubashynskaya, Natallia V and Petrova, Valentina A and Skorik, Yury A},
title = {Biopolymer Drug Delivery Systems for Oromucosal Application: Recent Trends in Pharmaceutical R&D},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {10},
pages = {5359},
doi = {10.3390/ijms25105359}
}
EUVIMED